^
    MAGE-A4 IHC 1F9 pharmDx is an immunohistochemistry (IHC) assay used to detect MAGE-A4 expression in formalin-fixed paraffin-embedded (FFPE) synovial sarcoma tissue. MAGE-A4 IHC 1F9 pharmDx is the first IVD for MAGE-A4 available on the market.
    Cancer:
    Synovial Sarcoma
    Gene:
    MAGEA4 (Melanoma antigen family A, 4)
    Method:
    Immunohistochemistry (IHC)
    Approvals
    Date
    Cancer
    Gene
    Drug
    By
    08/02/24
    SS
    MAGEA4
    FDA